The Epstein-Barr virus gene BHRF1, a homologue of the cellular oncogene bcl-2, inhibits apoptosis induced by gamma radiation and chemotherapeutic drugs

Advances in Experimental Medicine and Biology

Volumn 406, Issue , 1996, Pages 83-97

  McCarthy, N J ^a,b,c   Hazlewood, S A ^a,b   Huen, D S ^b   Rickinson, A B ^b   Williams, G T ^a,b  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; DNA; ETOPOSIDE; METHOTREXATE;

APOPTOSIS; ARTICLE; CELL VIABILITY; CHROMATIN CONDENSATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GAMMA RADIATION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; RAJI CELL; VIRUS GENE;

HUMAN HERPESVIRUS 4; INSECTA;

EID: 0029966208     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-0274-0_9     Document Type: Article

References (69)

1. M.J. Arends and Wyllie, A., Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol., 32, 223-254 (1991).
2. G.T. Williams, Smith, C.A., McCarthy, N.J. and Grimes, E.A., Apoptosis: Final control point in cell biology. Trends Cell. Biol., 2: 263-267 (1992).
3. A.J. Hale, Smith, C.A., Sutherland, L.C., Stoneman, V.E.A., Longthorne, V.L., Culhane, A.C. and Williams, G.T., Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 1996 (in the press).
4. C.A. Smith, Gimes, E.A., McCarthy, N.J. and Williams, G.T., Multiple gene regulation of apoptosis: Significance in immunology and oncology. In: L.D. Tomei and F.O. Cope (eds.), Apoptosis. The molecular basis of cell death II, Cold Spring Harbour Laboratory Press, Cold Spring Harbour, NY. (in press) (1994).
5. P. Golstein, Ojcius, D.M. and Young, J.D-E., Cell death mechanisms and the immune system. Immunol. Rev., 121: 29-65 (1991).
6. G.T. Williams. Apoptosis in the immune system. J. Pathol., 173: 1-4 (1994).
7. C.A. Smith, Williams, G.T., Kingston, R, Jenkinson, E.J. and Owen, J.J.T., Antibodies to the CD3/T-cell receptor complex induce death by apoptosis in immature T-cells in thymic cultures. Nature, 337: 181-184 (1989).
8. Y. Shi, Sahai, B.M. and Green, D.R., Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymoccytes. Nature, 339: 625-626 (1989).
9. Y.J. Liu, Cairns, J.A, Holder, M.J., Abbot, S.J., Jansen, K.U., Bonnefoy, J.Y., Gordon, J. and MacLennan, I.C.M.. Recombinant 25 kDa CD23 and interleukin 1α promote the survival of germinal centre B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur. J. Immunol. 21, 1107-1114 (1991).
10. G.J.V. Nossal. The molecular and cellular basis of affinity maturation in the antibody response. Cell, 68: 1-2 (1992).
11. G.T. Williams, Smith, C. A., Spooncer, E., Dexter, T.M and Taylor, D. R., Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature, 343: 76-79 (1990).
12. M.J. Koury and Bondurant, M.C., Control of red cell prodcution: the roles of programmed cell death (apoptosis) and erythropoietin. Transfusion, 30: 673-674 (1990).
13. D.L. Vaux, Cory, S. and Adams, J.M.. Bcl-2 gene promotes haemopoietic cell survival and co-operates with c-myc to immortalize pre-B cells. Nature, 335:440-42 (1988).
14. D. Hockenbery, Nunez, G., Milliman, C., Schreiber, R.D. and Korsmeyer, S.J., Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348: 334-336 (1990).
15. Y. Tsujimoto, Stress resistance conferred by high level of Bcl-2α protein in human B-lymphoblastoid cell. Oncogene, 4: 1331-1336 (1989).
16. N.J. McCarthy, Smith, C.A. and Williams, G.T., Apoptosis in the development of the immune system: Growth factors, clonal selection and bcl-2. Cancer Metastasis Rev., 11: 157-178 (1992).
17. M.L. Cleary, Smith, S.D. and Sklar J., Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell, 47: 19-28 (1986).
18. G.T. Williams, Programmed cell death: Apoptosis and oncogenesis. Cell, 65: 1097-1098 (1991).
19. S.A. Henderson, Huen, D., Rowe, M., Dawson, C., Johnson, G. and Rickinson, A., Epstein-Barr virus coded BHRF1 protein, a viral homologue of bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. U.S.A., 90: 8479-8483 (1993).
20. T. Hickish, Robertson, D., Clarke, P., Hill, M., di Stefano, F., Clarke, C. and Cunnigham, D., Ultrastructural localisation of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2. Cancer Res. 54, 2808-2811.
21. J.W. Gratama, Oosterveer, M.A.P., Zwann, F.E., Lepoutre, J., Klein, G. and Ernberg, I., Eradication of Epstein Barr virus by allogenic bone marrow transplantation: indications for sites of vital latency. Proc. Natl. Acad. Sci. USA, 85: 8693-8696 (1988).
22. Q.Y. Yao, Ogan, P., Rowe, M., Wood, M. and Rickinson, A.B., Epstein Barr virus infected B cells persist in the cirulation of acyclovir-treated virus carriers. Int. J. Cancer, 43: 67-71 (1989).
23. C.D. Gregory, Dive, C., Henderson, S.A., Smith, C.A., Williams, G.T., Gordon, J and Rickinson, A. B., Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature, 349: 612-614 (1991).
24. S.A. Henderson, Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E. and Rickinson, A., Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell, 65: 1107-1115 (1991).
25. E. White, Sabbatini, P. Debbas, M., Wold, W.S.M., Kusher, D. I. and Gooding L.R., The 19-Kilodalton Adenovirus E1b transforming protein inhibits programmed cell death and prevents cytolysis by tumour necrosis factor α. Mol. Cell. Biol., 12: 2570-2580.
26. J.L. Cleveland, Dean, M., Rosenberg, N., Wang, J.Y.J. and Rapp, U.R., Tyrosine kinase oncogenes abrogate interleukin 3 dependence of murine myeloid cells through signalling pathways involving c-myc: conditional regulation of c-myc transcription by temperature sensitive v-abl. Mol. Cell Biol., 9:5685-5695 (1989).
27. R.J. Clem, Fechheimer, M. and Miller L. K., Prevention of apoptosis by a Baculovirus gene during infection of insect cells. Science, 254: 1388-1390 (1991).
28. N.E. Crook, Clem, R.J. and Miller, L.K., An apoptosis inhibiting Baculovirus gene with a zinc finger like motif. J. Virol., 67: 2168-2174 (1993).
29. M. Hummel, and Kieff, E., Epstein Barr virus RNA VIII. Viral RNA in permissively infected B95-8 cells. J. Virol., 43: 262-272 (1982).
30. M. Hummel, and Kieff, E., Mapping of polypeptides encoded by the Epstein Barr virus genome in productive infection. Proc. Natl. Acad. Sci. U.S.A., 79: 5698-5702 (1982).
31. T.J. McDonnell, Deane, N., Platt, F.M, Nunez, G., Jaeger, U., McKearn, J.P. and Korsmeyer S. J., Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell: 57: 79-88 (1989).
32. T.J. McDonnell and Korsmeyer, S. J., Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature, 349: 254-256 (1991).
33. J.J. Oudejans, van den Brule, A.J., Jiwa, N.M., de Bruin, P.C., Ossenkoppele, G.J., van der Valk, P., Walboomers, J.M. and Meijer, C.J., BHRF1, the Epstein-Barr virus (EBV) homologue of the Bcl-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes. Blood, 86: 1893-1902 (1995).
34. T. Yamada, and Ohyama, H., Radiation-induced interphase death of rat thymocytes is internally programmed. Int. J. Radiat. Biol., 53: 65-75 (1988).
35. M.A. Barry, Behnke, C.A. and Eastman, A., Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol., 40: 2353-2362 (1990).
36. C.A. Evans, Owen-Lynch, P.J., Whetton, A.O. and Dive, C., Activation of the ableson tyrosine kinase activity is associated with suppression of apoptosis in haemopoietic cells. Cancer Res., 53: 1735-1738 (1993).
37. C.A. Dive and Hickman, J.A., Drug-target interactions: only the first step in a commitment to a programmed cell death. Br. J. Cancer, 64: 192-196 (1991).
38. M.K.L. Collins, Marvel, J., Malde, P. and Lopez-Rivas, A., Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J. Exp. Med., 176: 1043-1051 (1992).
39. T. Miyashita, and Reed, J.C., Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a leukaemia cell line. Blood, 81: 151-157 (1993).
40. A.H. Wyllie. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284: 555-556 (1980).
41. D.J. McConkey, Hartzell, P., Nicotera, P. and Orrenius, S., Calcium-activated DNA fragmentation kills immature thymocytes. FASEB J., 3: 1843-1849 (1989).
42. K.S. Sellins, and Cohen, J.J., Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J.Immunol., 139: 3199-3206 (1987).
43. A.J. Levine, Momand J. and Finlay, C.A., The p53 tumour suppressor gene. Nature, 351:453-456 (1991).
44. S.J. Baker, Fearon, E.R., Nigro, J.M., Hamilton, S.R., Preisinger, A.C., Jessup, J.M., vanTuinen, P., Ledbetter, D.H., Barker, D.F., Nakamura, Y., White, R. and Vogelstein, B., Chromosome 17 deletions and p53 gene mutations in colosectal carcinoma. Science, 244: 217-221 (1989).
45. S.W. Lowe, Schmitt, E.M., Smith, S.W., Osborne, B.A. and Jacks, T., p53 is required for radiation induced apoptosis in mouse thymocytes. Nature, 362, 847-849 (1993).
46. A.R. Clarke, Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L. and Wyllie, A.H., Thymocyte apoptosis induced by p53 dependent and independent pathways. Nature, 362: 849-852 (1993).
47. G.I. Evan, Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M, Waters, C.M. and Hancock, D. C., Induction of apoptosis in fibroblasts by c-myc protein. Cell, 63: 119-128 (1992).
48. L.H. Boise, Gonzalez-Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G. and Thompson, C.B., bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74: 597-609 (1993).
49. Z.N. Oltvai, Milliman, C.L. & Korsmeyer, S.J., Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619 (1993).
50. D.L. Vaux, Weissman, I.L. and Kim, S.K., Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science, 258: 1955-1957 (1992).
51. M.O. Hengartner, and Horvitz, H.R., C.elegans cell survival gene ced-9 encodes a functional homologue of the mammalian proto-oncogene bcl-2. Cell, 76: 665-676 (1994).
52. G.T. Williams, and Smith, C.A., Molecular regulation of apoptosis: Genetic controls on cell death. Cell, 74: 777-779 (1993).
53. J.G. Neilan, Lu, Z., Afonso, C.L., Kutish, G.F., Sussman, M.D. and Rock, D.L., An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRF1. J. Virol., 67: 4391-4394 (1993).
54. G.R. Pearson, Luka, J., Petti, L., Sample, J., Birkenbach, M., Braun, D. and Keiff, E., Identification of an Epstein Barr virus early gene encoding a second comonent of the restricted early antigen complex. Virology, 160: 151-161 (1987).
55. B. Tarodi, Subramanian, T. and Chinnadurai, G., Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology, 201: 404-407 (1994).
56. C.W. Dawson, Eliopoulos, A.G., Dawson, J. and Young, L.S., BHRF1, a viral homologue of the BCL-2 oncogene, disturbs epithelial cell differentiation. Oncogene, 10: 69-77 (1995).
57. R. Dalla-Favera, Martinotti, S., Gallo, R.C., Erikson, J. and Croce, C.M., Science, 219: 963-967 (1983).
58. F. Cavalli, Chemothreapy of non-Hodgkin's lymphoma. Bailliere's Clinical Haematology, 4: 157-179 (1991).
59. R. Juliano, and Ling, V., J. Supramol. Strut., 4: 521-526 (1976).
60. V. Ling. P-glycoprotein and resistance to anticancer drugs. Cancer, 69: 2603-2609 (1992).
61. P.F. Juranka, Zastawny, R.L. and Ling, V., P-glycoprotein multidrug-resistance and a super family of membrane-associated transport proteins. FASEB J., 3: 2583-2592 (1989).
62. G.H. Mickisch, Merlino, G.T., Galski, H., Gottesman, M.M. and Pastan, I. Transgenic mice that express the human multidrug resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. Proc. Natl. Acad. Sci. USA., 88: 547-551 (1991).
63. T.C. Fisher, Milner, A.E., Gregory, C.D., Jackman, A., Aherne, G.W., Hartley, J.A., Dive, C. and Hickman, J.A., bcl-2 modulation of apoptosis induced by anticancer drugs: Resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res., 53: 3321-3326 (1993).
64. M.I. Walton, Whysong, D., O'Connor, P.M., Hockenbery, D., Korsmeyer, S.J. and Kohn, K.W., Constitutive expression of human bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis. Cancer Res., 53: 1853-1861 (1993).
65. J. Lotem and Sachs, L. Regulation by bcl2-, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation competent and defective myeloid leukaemic cells. Cell Growth Diff., 4: 41-47 (1993).
66. C.M. Rooney, Gregory, C.D., Rowe, M., Finerty, S., Edwards, C., Rupani, H. and Rickinson, A.B., Endemic Burkitt's lymphoma: phenotypic analysis of Burkitt's lymphoma biopsy cell and of the derived tumour cell lines. J.Natl. Cancer Inst., 77: 681-687 (1986).
67. K. Takada and Ono. Y., Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J.Virol., 63: 445-449 (1989).
68. L. Rymo, Lindahl, T., Povey, S. and Klien, G., Anaylsis of restriction endonuclease fragments of intracellular Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of proteins. Virology, 115: 115-124 (1981).
69. A.H. Wyllie, Morris, R.G., Smith, A.L. and Dunlop, D., Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol., 142: 67-77 (1984).